While in our study only 2/20 STS had immunoreactivity for SOX-10 and an additional tumor expressed SOX10 RNA levels above the cutoff, five cases in the OSCT group had a strong immunoreactivity for SOX-10 and SOX10 RNA levels above the cutoff. The gene discussed is SOX10; the disease is neoplasm.